These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33670772)
1. Leber Congenital Amaurosis Due to Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Wu V; Swider M; Sheplock R; Krishnan AK; Garafalo AV Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670772 [TBL] [Abstract][Full Text] [Related]
2. Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations. Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Charng J; Lu M; Choudhury S; Schwartz SB; Heon E; Fishman GA; Boye SE Am J Ophthalmol; 2017 May; 177():44-57. PubMed ID: 28212877 [TBL] [Abstract][Full Text] [Related]
3. GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History Study in Preparation for Trials of Novel Therapies. Bouzia Z; Georgiou M; Hull S; Robson AG; Fujinami K; Rotsos T; Pontikos N; Arno G; Webster AR; Hardcastle AJ; Fiorentino A; Michaelides M Am J Ophthalmol; 2020 Feb; 210():59-70. PubMed ID: 31704230 [TBL] [Abstract][Full Text] [Related]
4. Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis. Pasadhika S; Fishman GA; Stone EM; Lindeman M; Zelkha R; Lopez I; Koenekoop RK; Shahidi M Invest Ophthalmol Vis Sci; 2010 May; 51(5):2608-14. PubMed ID: 19959640 [TBL] [Abstract][Full Text] [Related]
5. Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene. Aguirre GK; Butt OH; Datta R; Roman AJ; Sumaroka A; Schwartz SB; Cideciyan AV; Jacobson SG Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):959-973. PubMed ID: 28403437 [TBL] [Abstract][Full Text] [Related]
6. Outcome measure for the treatment of cone photoreceptor diseases: orientation to a scene with cone-only contrast. Roman AJ; Cideciyan AV; Matsui R; Sheplock R; Schwartz SB; Jacobson SG BMC Ophthalmol; 2015 Aug; 15():98. PubMed ID: 26253563 [TBL] [Abstract][Full Text] [Related]
7. Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants. Jacobson SG; Cideciyan AV; Peshenko IV; Sumaroka A; Olshevskaya EV; Cao L; Schwartz SB; Roman AJ; Olivares MB; Sadigh S; Yau KW; Heon E; Stone EM; Dizhoor AM Hum Mol Genet; 2013 Jan; 22(1):168-83. PubMed ID: 23035049 [TBL] [Abstract][Full Text] [Related]
8. Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D. Stunkel ML; Brodie SE; Cideciyan AV; Pfeifer WL; Kennedy EL; Stone EM; Jacobson SG; Drack AV Am J Ophthalmol; 2018 Jun; 190():58-68. PubMed ID: 29559409 [TBL] [Abstract][Full Text] [Related]
9. Leber congenital amaurosis caused by mutations in GUCY2D. Boye SE Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a017350. PubMed ID: 25256176 [TBL] [Abstract][Full Text] [Related]
10. Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1. Boye SL; Peterson JJ; Choudhury S; Min SH; Ruan Q; McCullough KT; Zhang Z; Olshevskaya EV; Peshenko IV; Hauswirth WW; Ding XQ; Dizhoor AM; Boye SE Hum Gene Ther; 2015 Sep; 26(9):575-92. PubMed ID: 26247368 [TBL] [Abstract][Full Text] [Related]
11. Novel GUCY2D mutation causes phenotypic variability of Leber congenital amaurosis in a large kindred. Gradstein L; Zolotushko J; Sergeev YV; Lavy I; Narkis G; Perez Y; Guigui S; Sharon D; Banin E; Walter E; Lifshitz T; Birk OS BMC Med Genet; 2016 Jul; 17(1):52. PubMed ID: 27475985 [TBL] [Abstract][Full Text] [Related]
12. Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiency. Mihelec M; Pearson RA; Robbie SJ; Buch PK; Azam SA; Bainbridge JW; Smith AJ; Ali RR Hum Gene Ther; 2011 Oct; 22(10):1179-90. PubMed ID: 21671801 [TBL] [Abstract][Full Text] [Related]
13. The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene. Hahn LC; Georgiou M; Almushattat H; van Schooneveld MJ; de Carvalho ER; Wesseling NL; Ten Brink JB; Florijn RJ; Lissenberg-Witte BI; Strubbe I; van Cauwenbergh C; de Zaeytijd J; Walraedt S; de Baere E; Mukherjee R; McKibbin M; Meester-Smoor MA; Thiadens AAHJ; Al-Khuzaei S; Akyol E; Lotery AJ; van Genderen MM; Ossewaarde-van Norel J; van den Born LI; Hoyng CB; Klaver CCW; Downes SM; Bergen AA; Leroy BP; Michaelides M; Boon CJF Ophthalmol Retina; 2022 Aug; 6(8):711-722. PubMed ID: 35314386 [TBL] [Abstract][Full Text] [Related]
14. Possible dual contribution of a novel GUCY2D mutation in the development of retinal degeneration in a consanguineous population. Salehi Chaleshtori AR; Garshasbi M; Salehi A; Noruzinia M Eur J Med Genet; 2020 Mar; 63(3):103750. PubMed ID: 31470097 [TBL] [Abstract][Full Text] [Related]
16. Outcome Measures for Clinical Trials of Leber Congenital Amaurosis Caused by the Intronic Mutation in the CEP290 Gene. Jacobson SG; Cideciyan AV; Sumaroka A; Roman AJ; Charng J; Lu M; Choi W; Sheplock R; Swider M; Kosyk MS; Schwartz SB; Stone EM; Fishman GA Invest Ophthalmol Vis Sci; 2017 May; 58(5):2609-2622. PubMed ID: 28510626 [TBL] [Abstract][Full Text] [Related]
17. Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy. Boye SE; Huang WC; Roman AJ; Sumaroka A; Boye SL; Ryals RC; Olivares MB; Ruan Q; Tucker BA; Stone EM; Swaroop A; Cideciyan AV; Hauswirth WW; Jacobson SG PLoS One; 2014; 9(3):e92928. PubMed ID: 24671090 [TBL] [Abstract][Full Text] [Related]
18. Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining. Jacobson SG; Cideciyan AV; Aleman TS; Sumaroka A; Roman AJ; Swider M; Schwartz SB; Banin E; Stone EM Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):70-9. PubMed ID: 20702822 [TBL] [Abstract][Full Text] [Related]
19. AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis. Boye SL; Peshenko IV; Huang WC; Min SH; McDoom I; Kay CN; Liu X; Dyka FM; Foster TC; Umino Y; Karan S; Jacobson SG; Baehr W; Dizhoor A; Hauswirth WW; Boye SE Hum Gene Ther; 2013 Feb; 24(2):189-202. PubMed ID: 23210611 [TBL] [Abstract][Full Text] [Related]